Skeletal Targeted Radiotherapy: Updated Phase I/II data

Six-year follow-up data from a dose-escalation Phase I/II trial in 83 patients showed

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE